NCT07747337

Brief Summary

The goal of this observational study is to evaluate respiratory and limb muscle properties in adults awaiting lung transplantation and determine how these measures relate to physical performance, symptoms, and recovery after transplantation. Respiratory and limb muscle weakness may contribute to impaired mobility, frailty, and delayed postoperative recovery, but their specific role in lung transplant candidates is not well understood. Participants will undergo muscle ultrasound imaging at weekly basis, respiratory and limb strength testing, physical performance assessments, and symptom questionnaires once before and after transplantation. Researchers will also collect information from medical records regarding intensive care unit stay, hospital length of stay, rehabilitation participation, and postoperative recovery outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Feb 2026Jul 2027

Study Start

First participant enrolled

February 5, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 5, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

August 5, 2026

Status Verified

July 1, 2026

Enrollment Period

10 months

First QC Date

July 27, 2026

Last Update Submit

July 30, 2026

Conditions

Keywords

lung transplant candidatesdiaphragm ultrasoundlimb muscles ultrasoundrespiratory musclesquadriceps musclesrehabilitation

Outcome Measures

Primary Outcomes (5)

  • Diaphragm structure

    Diaphragm thickness (unit of measure: mm) assessed by ultrasonography

    Weekly from baseline through postoperative day 14 (±2 days)

  • Respiratory Muscle Strength

    Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) obtained during maximal respiratory efforts against a one-way valve.

    Baseline and at postoperative day 14 (±2 days)

  • Abdominal muscle structure

    Rectus abdominis muscle thickness (measurement unit: mm) assessed by ultrasonography.

    Baseline through postoperative day 14 (±2 days)

  • Limb muscle strength

    Handgrip force and knee extension force measured using dynamometry.

    At the first baseline visit and postoperative day 14 (±2 days)

  • Rectus femoris thickness

    Rectus femoris muscle thickness (unit of measurement: mm) assessed by ultrasonography.

    Baseline through postoperative day 14 (±2 days)

Secondary Outcomes (5)

  • Five-Repetition Sit-to-Stand Test

    Baseline and hospital discharge

  • Frailty Status

    Baseline and at postoperative day 14 (±2 days)

  • patient-reported symptoms

    Baseline and at postoperative day 14 (±2 days)

  • Six-Minute Walk Distance

    Baseline and at hospital discharge, an average of 3 weeks after surgery.

  • Anxiety

    Baseline and at hospital discharge, up to an average of 3 weeks after surgery.

Other Outcomes (3)

  • Duration of Mechanical Ventilation

    From surgery through hospital discharge, up to an average of 3 weeks after surgery.

  • Intensive Care Unit Length of Stay

    From ICU admission through ICU discharge, up to an average of two weeks after surgery.

  • Hospital Length of Stay

    From ICU admission through hospital discharge, up to an average of 3 weeks after surgery.

Study Arms (1)

Adult Lung Transplant Candidates

adults enrolled for in-hospital evaluation for lung transplant and listed for surgery who undergo serial assessments of respiratory and limb muscle properties before transplantation and during the early postoperative period. Assessments include ultrasound imaging, respiratory and limb strength testing, physical performance measures, patient-reported outcomes, and collection of clinical outcomes from the medical record.

Diagnostic Test: Respiratory and Limb Muscle Assessment

Interventions

Participants undergo serial assessments of respiratory and limb muscle structure and function before and after lung transplantation. Assessments include ultrasound imaging of the diaphragm, rectus abdominis, and quadriceps muscles; respiratory muscle strength testing; handgrip strength testing; knee extension strength testing; physical performance measures; and patient-reported outcome questionnaires.

Adult Lung Transplant Candidates

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult lung transplant candidates receiving care at UF Shands hospital. Participants are individuals with advanced lung disease undergoing evaluation and treatment while awaiting lung transplantation in the hospital. The study population includes adults who are able to complete study assessments of respiratory and limb muscle function before transplantation and during the early postoperative recovery period.

You may qualify if:

  • years or older.
  • Hospitalized as potential candidates for single- or bilateral-lung transplant surgery.
  • Hemodynamically stable for out-of-bed mobilization

You may not qualify if:

  • Baseline cognitive impairment
  • History of previous solid organ transplantation or thoracic surgery
  • Existing phrenic nerve lesion
  • Lower limb amputation or fracture
  • External fixators or open wounds of the lower extremities
  • Diagnosed neuromuscular disorder.
  • Morbid obesity (body mass index \>45 kg/m²).
  • Any other medical condition that, in the opinion of the investigators, would make participation unsuitable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health Shands Medical Center

Gainesville, Florida, 32608, United States

RECRUITING

Related Publications (6)

  • Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, Troosters T. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant. 2008 Jun;8(6):1275-81. doi: 10.1111/j.1600-6143.2008.02209.x. Epub 2008 Apr 29.

    PMID: 18444941BACKGROUND
  • Parry SM, El-Ansary D, Cartwright MS, Sarwal A, Berney S, Koopman R, Annoni R, Puthucheary Z, Gordon IR, Morris PE, Denehy L. Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function. J Crit Care. 2015 Oct;30(5):1151.e9-14. doi: 10.1016/j.jcrc.2015.05.024. Epub 2015 Jun 3.

    PMID: 26211979BACKGROUND
  • Huh S, Cho WH, Kim D, Son BS, Yeo HJ. Clinical impact of preoperative diaphragm dysfunction on early outcomes and ventilation function in lung transplant: a single-center retrospective study. J Intensive Care. 2022 May 15;10(1):23. doi: 10.1186/s40560-022-00614-7.

    PMID: 35570300BACKGROUND
  • LoMauro A, Righi I, Privitera E, Vergari M, Nigro M, Aliverti A, Frykholm P, Tarsia P, Morlacchi L, Nosotti M, Palleschi A. The impaired diaphragmatic function after bilateral lung transplantation: A multifactorial longitudinal study. J Heart Lung Transplant. 2020 Aug;39(8):795-804. doi: 10.1016/j.healun.2020.04.010. Epub 2020 Apr 21.

    PMID: 32362476BACKGROUND
  • Kelm DJ, Bonnes SL, Jensen MD, Eiken PW, Hathcock MA, Kremers WK, Kennedy CC. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transplant. 2016 Mar;30(3):247-55. doi: 10.1111/ctr.12683. Epub 2016 Feb 11.

    PMID: 26701203BACKGROUND
  • Rozenberg D, Wickerson L, Singer LG, Mathur S. Sarcopenia in lung transplantation: a systematic review. J Heart Lung Transplant. 2014 Dec;33(12):1203-12. doi: 10.1016/j.healun.2014.06.003. Epub 2014 Jun 9.

    PMID: 25044057BACKGROUND

MeSH Terms

Interventions

Respiratory Rate

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Central Study Contacts

Barbara K Smith, PhD, PT

CONTACT

Wagner Souza Leite, PT

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2026

First Posted

August 5, 2026

Study Start

February 5, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

August 5, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Participant data that underlie the results reported in this article after deidentification.

Shared Documents
STUDY PROTOCOL
Time Frame
9 months and ending 36 months following article publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee.

Locations